retatrutide safety clinical trials retatrutide What is and How to Get It Safely? Phase III retatrutide study demonstrates

GLP-1 receptor agonists in binge eating disorder: a narrative review

Older adults may need slower dose escalation to minimize side effects

Glucagon-like peptide 1based therapies and risk of pancreatic cancer in patients with diabetes and obesity

An MHRA spokesperson said: Alongside increased usage, we are seeing an upturn in the number of Yellow Card reports mentioning GLP-1 medicines and acute pancreatitis. Due to the impact of this serious disease on patients, the MHRA said it wanted to understand whether there were any genetic factors at play

Studies on compounded tirzepatide formulations show that temperature excursions above the recommended range cause molecular degradation that is not visible to the naked eye

Illinois Despite the fiscal constraints in rendering coverage for these drugs on the state employee health plan, some states are staying the course